NH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.3
| Stock Code | NH | Market Cap | 34,541 Cr. | Current Price | 1,688 ₹ | High / Low | 2,372 ₹ |
| Stock P/E | 69.9 | Book Value | 114 ₹ | Dividend Yield | 0.27 % | ROCE | 19.4 % |
| ROE | 21.0 % | Face Value | 10.0 ₹ | DMA 50 | 1,788 ₹ | DMA 200 | 1,781 ₹ |
| Chg in FII Hold | 0.61 % | Chg in DII Hold | 0.15 % | PAT Qtr | 109 Cr. | PAT Prev Qtr | 138 Cr. |
| RSI | 39.5 | MACD | -39.2 | Volume | 2,20,135 | Avg Vol 1Wk | 3,59,806 |
| Low price | 1,380 ₹ | High price | 2,372 ₹ | PEG Ratio | 1.51 | Debt to equity | 0.69 |
| 52w Index | 31.1 % | Qtr Profit Var | 37.1 % | EPS | 22.6 ₹ | Industry PE | 43.5 |
📊 Analysis: NH is trading at ₹1,688, below both its 50 DMA (₹1,788) and 200 DMA (₹1,781), reflecting short-term weakness. RSI at 39.5 indicates oversold-to-weak momentum, while MACD (-39.2) confirms bearish bias. Intraday volume (2.2 lakh) is lower than the 1-week average (3.6 lakh), suggesting reduced participation. Fundamentals show strong ROE (21.0%) and ROCE (19.4%), but valuation is stretched with P/E 69.9 vs industry 43.5. EPS of ₹22.6 supports earnings, though quarterly PAT declined from ₹138 Cr. to ₹109 Cr.
💰 Optimal Buy Price: Intraday entry may be considered near ₹1,675–1,685 if momentum stabilizes.
🎯 Exit Levels:
- Profit-taking: ₹1,710 – ₹1,725 (near-term resistance)
- Stop-loss: ₹1,660 (below intraday support)
⏱️ If Already Holding: Exit should be considered if price fails to hold above ₹1,675 or if RSI drops below 38 intraday. Watch for volume spikes near ₹1,710–1,725 to book profits.
Positive
- Strong ROE (21.0%) and ROCE (19.4%) indicate efficient capital use.
- EPS of ₹22.6 supports valuation strength.
- FII holding increased (+0.61%), showing foreign investor confidence.
- DII holding increased (+0.15%), reflecting domestic institutional support.
Limitation
- High P/E (69.9) compared to industry average (43.5).
- Trading below both 50 DMA and 200 DMA reflects bearish sentiment.
- Low dividend yield (0.27%) offers limited investor returns.
Company Negative News
- Quarterly PAT declined from ₹138 Cr. to ₹109 Cr.
- Volume below average, reducing intraday strength.
Company Positive News
- Quarterly profit variation (+37.1%) shows improvement despite lower PAT.
- 52-week index return of 31.1% reflects investor confidence.
Industry
- Industry PE at 43.5 is lower, making NH relatively expensive compared to peers.
- Healthcare sector benefits from long-term demand growth and defensive positioning.
Conclusion
⚖️ NH shows weak short-term momentum with RSI near oversold levels and MACD negative. Intraday traders may consider entries near ₹1,675–1,685 with profit targets around ₹1,710–1,725. A tight stop-loss at ₹1,660 is recommended. Conservative traders should wait for confirmation above ₹1,725 before fresh entries.
Would you like me to extend this into a peer benchmarking overlay comparing NH with Apollo Hospitals, Fortis, and Max Healthcare to highlight relative intraday strength and sector rotation opportunities within the healthcare sector?